Free Trial

Trading of Polyrizon was halted at 11:09 AM EST due to "LULD pause".

NASDAQ:PLRZ

Polyrizon (PLRZ) Stock Price, News & Analysis

Polyrizon logo
$1.03 +0.38 (+59.44%)
As of 04:00 PM Eastern

About Polyrizon Stock (NASDAQ:PLRZ)

Key Stats

Today's Range
$0.70
$1.62
50-Day Range
$0.00
$1.14
52-Week Range
$0.55
$1,200.00
Volume
51.57 million shs
Average Volume
728,695 shs
Market Capitalization
$4.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Polyrizon Ltd. is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.

Receive PLRZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Polyrizon and its competitors with MarketBeat's FREE daily newsletter.

PLRZ Stock News Headlines

Trump’s Bitcoin Reserve is No Accident…
For the first time in history, we have a president who understands crypto's potential to bypass the banking system entirely. And Wall Street's biggest players know it. I've created a blueprint revealing how everyday investors can turn this historic shift into potentially life-changing wealth. Like the 75,000 new millionaires created in the last bull run— only this time with institutional backing.
See More Headlines

PLRZ Stock Analysis - Frequently Asked Questions

Polyrizon's stock was trading at $2.17 at the start of the year. Since then, PLRZ shares have decreased by 52.5% and is now trading at $1.03.
View the best growth stocks for 2025 here
.

Polyrizon shares reverse split before market open on Tuesday, May 27th 2025. A 1-250 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Monday, May 26th 2025. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

Polyrizon (PLRZ) raised $4 million in an initial public offering on Tuesday, October 29th 2024. The company issued 958,903 shares at a price of $4.38 per share.

Polyrizon's lock-up period expired on Monday, April 28th. Polyrizon had issued 958,903 shares in its IPO on October 29th. The total size of the offering was $4,199,995 based on an initial share price of $4.38. Shares of the company owned by company insiders and major shareholders are now eligible to be traded as a result of the expiration of the lock-up period.

Shares of PLRZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
5/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PLRZ
Previous Symbol
NASDAQ:PLRZ
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$2.96 million
Optionable
N/A
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (NASDAQ:PLRZ) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners